Navigation Links
Biocept, Inc. Announces Two New Director Appointments
Date:7/1/2009

SAN DIEGO, July 1 /PRNewswire/ -- Biocept, Inc. ("Biocept"), an emerging leader in biotechnology, announced today the appointment of Daniel H. Petree and M. Faye Wilson as Directors.

"We are pleased to welcome Dan and Faye to our Board. Their experience will be invaluable to us as we move into our next stage of development," said Stephen M. Coutts, President and CEO.

Ms. Wilson has been a principal of Wilson Boyles and Company, a business management and strategic planning consulting firm, since 2003. She served on the board of directors of Farmers Insurance Group of Companies from 1993 through 2001 and the board of directors of The Home Depot, Inc. from 1992 through 2001. Ms. Wilson was also a senior officer of Home Depot from 1998 through 2002. From 1992 until 1998, Ms. Wilson served in several senior management roles at Bank of America Corporation including Chairman of Security Pacific Financial Services and Executive Vice President and Chief Credit Officer for Bank of America's National Consumer Banking Group. She earned her Masters Degrees in International Relations and Business Administration from the University of Southern California and an Undergraduate Degree from Duke University. She became a certified public accountant in 1961.

Daniel Petree has over 20 years of experience in the biotechnology industry, serving in a variety of roles including investment banker, senior operating manager and corporate and securities lawyer. Mr. Petree is a founder and member of P2 Partners, LLC, a boutique investment bank specializing in life science companies. Prior to forming P2 Partners, Mr. Petree held various executive management positions in the life sciences industry, including President and Chief Operating Officer of Axys Pharmaceuticals and Vice President of Business Development at TSI Corporation. He also served as Vice President in the Health Care Group at the investment bank Montgo
'/>"/>

SOURCE Biocept, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Biocept, Inc. Announces CEO and Director Appointments
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
4. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
5. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
6. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
7. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2009)...experience in data analysis combined with Bio-Rad,...kits and curricula provide state-of-the-art soluti...Ore., Nov. 18 Vernier Software &am...nterfaces, sensors, and software and Bio-Rad Labor...stributor of life science research and clinical di...
(Date:11/18/2009)...D, West Sussex, U.K. and CLEVELAND, Nov. 18 /PRNew...ciences business and premier provider of diagnosti...logy labs, has expanded its East Grinstead, U.K., ...y to meet increasing global demand for its Sensiti...tification testing. The expanded facility has been...
(Date:11/18/2009)...N, Nov. 18 /PRNewswire-FirstCall/ - YM BioSciences... product development company that identifies and a...lated products at various stages of development, a...tuzumab were presented today in a poster at the 20...rapeutics conference in Boston, Massachusetts. The...
(Date:11/18/2009)...NGS, Fla., Nov. 18 Algenol Biofuel...ology, and the technology group The Linde Group ...project in order to identify the optimum managemen...nol,s unique algae and photobioreactor technology....es to develop cost-efficient technologies that cap...
Breaking Biology Technology:Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 3TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 4YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 3Algenol Biofuels and The Linde Group Agree To Cooperate in CO2 and O2 Management For Biofuel Production From Algae 2Algenol Biofuels and The Linde Group Agree To Cooperate in CO2 and O2 Management For Biofuel Production From Algae 3
... and Launch of Hospira,s First Similar Biologic Ex...08 -, LAKE FOREST, Ill., Oct. 19 Hospira (NYSE:,...announced today that it,has received a "positive o...for Retacrit (epoetin zeta), a treatment for anemi...herapy-induced anemia. Retacrit is a similar,biolo...
...ts-Kind Integrated Biotech Facility for Biorefiner...oward Oil Independence, NORWELL, Mass., Oct. 18 ...e and technology leader in the development of,bior...icals from renewable,resources, announced today th...n research center at 42 Cummings Park in Woburn, M...
...A, Calif., Oct. 18 Coherent, Inc.,(Nasdaq: COHR ...inancial,results after the market close and host a... 2007 results scheduled for Wednesday, November 7,...live over the Internet and can be accessed,at eith.../www.earnings.com .,For those who are not availabl...
Other Biology Technology:Hospira's Biosimilar Epoetin Retacrit(TM) Receives Positive Opinion Recommending EU Approval 2Hospira's Biosimilar Epoetin Retacrit(TM) Receives Positive Opinion Recommending EU Approval 3BioEnergy International Facility Opens in Bay State 2BioEnergy International Facility Opens in Bay State 3BioEnergy International Facility Opens in Bay State 4
(Date:11/19/2009)... NIH Director,s T-R01 Award , Speedier Lab Testin... Jaffrey, associate professor of pharmacology at W...esearchers to win a prestigious NIH Director,s Tra... of Health. Dr. Jaffrey and his colleagues are dev...s that may some day speed up lab testing by instan...
(Date:11/19/2009)...e professor in the Fischell Department of Bioengin...oscience Research and Technology Review Day with a...one and other types of tissue for implantation. ,...resented in an eight minute pitch by faculty membe...Fair, held November 12 at the University of Maryla...
(Date:11/19/2009)... have shown how an experimental drug might restore...uries by preventing short circuits caused when tin..., The chemical compound also might be developed ... nerves usually are not severed in a common type o...s, the drug offers hope as a possible treatment, s...
Breaking Biology News(10 mins):Weill Cornell science briefs: November 2009 2Weill Cornell science briefs: November 2009 3Weill Cornell science briefs: November 2009 4Weill Cornell science briefs: November 2009 5Bioreactor for bone tissue engineering wins professor venture fair 2Bioreactor for bone tissue engineering wins professor venture fair 3Drug studied as possible treatment for spinal injuries 2Drug studied as possible treatment for spinal injuries 3New research reveals the ancestral populations of India and their relationships to modern groups 14244 1New research reveals the ancestral populations of India and their relationships to modern groups 14244 2New research reveals the ancestral populations of India and their relationships to modern groups 14244 3Caraco Pharmaceutical Laboratories Ltd Announces Resignation of Georges Ugeux from Board of Directors 58209 1Caraco Pharmaceutical Laboratories Ltd Announces Resignation of Georges Ugeux from Board of Directors 58209 2Caraco Pharmaceutical Laboratories Ltd Announces Resignation of Georges Ugeux from Board of Directors 58209 3Fair Elections Now Coalition Praises Rep Peter DeFazio for Cosponsoring Fair Elections Now Act 58204 1
...pun off its third company: MedTrust Online, a reli...ogists. , The for-profit, privately held MedTrust...ing genetic-based medical discoveries by the non-p...ch Institute. , Scottsdale-based MedTrust Online ...y need to design the best tailor-made treatments f...
...has highlighted a link between childhood obesity a...e work in animals proves that overweight expectant...body fat, who are at greater risk of diabetes and ...us research shows that around 30 percent of women ...h, published in the journal Endocrinology , shows...
...etin Board: BMRX), the leading developer of consum...d that Frank Santamorena, a world,renowned securit...ors,effective October 21, 2008., Frank Santamoren...ecurity expertise. Frank is a consultant to Honeyw...olutions, Diebold, Inc., BOSCH, NetApp,SimplexGrin...
Other Biology News:TGen spin-off MedTrust Online enables cancer doctors to quickly obtain best-available information 2Overweight mums have chubby bubs 2bioMETRX, Inc. Welcomes Residential and Commercial Security Expert to Board of Directors 2bioMETRX, Inc. Welcomes Residential and Commercial Security Expert to Board of Directors 3
Mouse Anti-Yersinia pestis F1 antigen Monoclonal Antibody, Unconjugated, Clone YPF19 from Abcam
...radient system uses three Adept CE 4100 high pres... in one microlitre increaments. The Adept CE 4200...System control and data processing is provided by ... unit, CE 4900., Column heater/chillers can be su...
Oligonucleotides from Thermo Scientific
Rabbit Anti-Human MSY2 / YBOX2 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: